IMMUNOLOGICAL MARKERS OF LONG-TERM EFFECTS OF TREATMENT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
- Authors: Krynskiy SA1, Malashenkova IK1,2, Hailov NA1, Ogurtsov DP1,2, Chekulaeva EI1, Ponomareva EV3, Gavrilova SI3, Didkovsky NA2
-
Affiliations:
- NRC “Kurchatov Institute”
- FSBI FCRC of Physical-Chemical Medicine FMBA of Russia, Moscow
- FSBSI “Mental Health Research Center”, Moscow
- Issue: Vol 19, No 1S (2019)
- Pages: 84-86
- Section: Articles
- URL: https://journal-vniispk.ru/MAJ/article/view/19338
- ID: 19338
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
S A Krynskiy
NRC “Kurchatov Institute”
I K Malashenkova
NRC “Kurchatov Institute”; FSBI FCRC of Physical-Chemical Medicine FMBA of Russia, Moscow
N A Hailov
NRC “Kurchatov Institute”
D P Ogurtsov
NRC “Kurchatov Institute”; FSBI FCRC of Physical-Chemical Medicine FMBA of Russia, Moscow
E I Chekulaeva
NRC “Kurchatov Institute”
E V Ponomareva
FSBSI “Mental Health Research Center”, Moscow
S I Gavrilova
FSBSI “Mental Health Research Center”, Moscow
N A Didkovsky
FSBI FCRC of Physical-Chemical Medicine FMBA of Russia, Moscow
References
- Manly JJ, Tang MX, Schupf N, et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol. 2008;63(4):494-506. https://doi.org/10.1002/ana.21326.
- Palmer K, Fratiglioni L, Winblad B. What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment. Acta Neurol Scand. 2003;179:14-20.
- Skaper SD, Facci L, Zusso M, Giusti P. An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. Front Cell Neurosci. 2018;12:72. eCollection 2018. https://doi.org/10.3389/fncel.2018.00072.
- Petersen RC, Touchon J. Consensus on mild cognitive impairment. Research and Practice in Alzheimer’s Disease, E.A.D.C./A.D.C.S. Joint Meeting (Serdi Publisher, Paris). 2005;10:24-32.
Supplementary files
